Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update

K Engle, G Kumar - European journal of medicinal chemistry, 2022 - Elsevier
Chemotherapy is one of the most common treatments for cancer that uses one or more anti-
cancer drugs as a part of the standardized chemotherapy regimen. Cytotoxic chemicals …

Strategies to therapeutically modulate cytokine action

WJ Leonard, JX Lin - Nature Reviews Drug Discovery, 2023 - nature.com
Cytokines are secreted or membrane-presented molecules that mediate broad cellular
functions, including development, differentiation, growth and survival. Accordingly, the …

[HTML][HTML] Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review

VN Dahl, M Mølhave, A Fløe, J van Ingen… - International Journal of …, 2022 - Elsevier
Objectives To describe the global trends of pulmonary nontuberculous mycobacteria (NTM)
infection and disease. Methods A systematic review of studies including culture-based NTM …

Applications, challenges, and needs for employing synthetic biology beyond the lab

SM Brooks, HS Alper - Nature Communications, 2021 - nature.com
Synthetic biology holds great promise for addressing global needs. However, most current
developments are not immediately translatable to 'outside-the-lab'scenarios that differ from …

An analysis of FDA-approved drugs: natural products and their derivatives

E Patridge, P Gareiss, MS Kinch, D Hoyer - Drug discovery today, 2016 - Elsevier
Highlights•Natural products contribute more than one-third of all FDA-approved NMEs.•The
absolute number of natural product approvals peaked in the 1990s and has since …

Systematic review of safety and efficacy of IL-1-targeted biologics in treating immune-mediated disorders

DD Arnold, A Yalamanoglu, O Boyman - Frontiers in immunology, 2022 - frontiersin.org
Background The cytokine interleukin (IL)-1 plays a pivotal role in immune-mediated
disorders, particularly in autoinflammatory diseases. Targeting this cytokine proved to be …

Programming gene and engineered-cell therapies with synthetic biology

T Kitada, B DiAndreth, B Teague, R Weiss - Science, 2018 - science.org
BACKGROUND Gene and engineered-cell therapies promise new treatment modalities for
incurable or difficult-to-treat diseases. First-generation gene and engineered-cell therapies …

Biotechnology and the bioeconomy—Towards inclusive and sustainable industrial development

Y Lokko, M Heijde, K Schebesta, P Scholtès… - New biotechnology, 2018 - Elsevier
To transform developing and least developing countries into industrialised ones,
biotechnology could be deployed along the value chain, to provide support to the …

Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis

S Aykul, E Martinez-Hackert - Analytical biochemistry, 2016 - Elsevier
Half-maximal inhibitory concentration (IC 50) is the most widely used and informative
measure of a drug's efficacy. It indicates how much drug is needed to inhibit a biological …

Microneedle-mediated transdermal delivery of biopharmaceuticals

HX Nguyen, CN Nguyen - Pharmaceutics, 2023 - mdpi.com
Transdermal delivery provides numerous benefits over conventional routes of
administration. However, this strategy is generally limited to a few molecules with specific …